Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bronchiectasis: full-pipeline trial registry
8 of 14 indexed Bronchiectasis trials are currently recruiting.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 8 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Bronchiectasis: 14 US clinical trials tracked, 8 recruiting.
Bronchiectasis is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Boehringer Ingelheim, running 3 of these trials.
Enrollment posture brief
Registry condition bronchiectasis
OPEN 8 | RECR 57% | LATE 3 | EARLY 4 | RANK #1230 | SPON 3
Volume-matched condition peers
Nearest open-share peer: ACL (57% recruiting · 7 trials)
Bronchiectasis lists 8 open slots (57% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bronchiectasis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bronchiectasis is recruiting above its size-band peers.
8 of 14 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Bronchiectasis research.
Boehringer Ingelheim accounts for 3 of 14 trials (21.4%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Bronchiectasis trials plan to enrol fewer than 100 people.
Median target enrolment is 64 among the 14 trials that report a genuine target (sentinel values excluded). 9 of those (64.3%) plan for fewer than 100 participants.
-
Bronchiectasis research is mostly interventional.
11 interventional and 3 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Boehringer Ingelheim
NCT06872892
Evaluation Of The Lung Microbiome In NTM Bronchiectasis
NYU Langone Health
NCT02779478
Natural History of Bronchiectasis
National Heart, Lung, and Blood Institute (NHLBI)
NCT00943514
Acoustic Waveform Respiratory Evaluation
Indiana University
NCT06512064
OLE Therapy With BE Patients in Home Care Study
Delve Health
NCT06926881
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
MGH Institute of Health Professions
NCT06304207
Itraconazole Therapy In Bronchiectasis With Airway Mold
Mayo Clinic
NCT07283497
Hypertonic Saline in NCFB
University of North Carolina, Chapel Hill
NCT06242795
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
Boehringer Ingelheim
NCT05846230
Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
Insmed Incorporated
NCT00775138
A Study of Home-based Pulmonary Rehabilitation and Health Coaching to Treat Bronchiectasis
Mayo Clinic
NCT05553119
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
University of North Carolina, Chapel Hill
NCT01615484
A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)
Boehringer Ingelheim
NCT05865886
A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Ansun Biopharma
NCT01113034
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Bronchiectasis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bronchiectasis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bronchiectasis page
14 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Bronchiectasis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Boehringer Ingelheim sponsors the most Bronchiectasis trials on record, review their full trial history before evaluating a specific study. See Boehringer Ingelheim's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bronchiectasis condition card totals 14 registered trials; most-linked intervention BI 1291583; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.